Comparison Between Latanoprost , Travoprost and Tafluprost in Reducing IOP Fluctuation in POAG Patients

Condition:   Primary Open Angle Glaucoma Interventions:   Drug: Latanoprost 0.005% Ophthalmic Solution;   Drug: Travoprost 0.004% ophthalmic solution;   Drug: Tafluprost Ophthalmic 0.0015% Ophthalmic Solution Sponsor:   Kasr El Aini Hospital Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials